Quad Screen | FßSM

The Quad Screen | FßSM determines a mother’s risk for having a baby with Down Syndrome, Trisomy 18 or Open Neural Tube Defects (ONTD).

Performed between 15 weeks and 21 weeks, 6 days gestation, it is a prenatal test that uses data from biochemical markers to yield a personalized risk assessment for your patient.

The Quad Screen is a stand-alone second trimester screen that uses the same as Part 2 of the Sequential Screen | FßSM, for cases where Part 1 (the First Trimester Screen | FßSM) was not performed .

Doctor talking with pregnant woman

How It Works

Detection

Down syndrome

Detection Rate
False Positive

Trisomy 18 (Edwards Syndrome)

Detection Rate
False Positive

Open Spina Bifida

Detection Rate
False Positive

Anencephaly

Detection Rate
False Positive

Test Results

Turn around time: Results can be expected 1-3 days from the time the sample is received at the laboratory.

More Insight into Potential Outcomes with Screening Report Flags

Physicians can have valuable comments added to patient reports that flag the risk of other potential adverse pregnancy outcomes associated with your patients’ extremely high or low analyte levels. With these comments, you can provide your patients with a more comprehensive pregnancy risk assessment as early as 1 day gestation. With these comments, you can provide your patients with a more comprehensive pregnancy risk assessment.

Learn more about how to opt-in for prenatal report flags.

Learn more about why NTD Eurofins has been the laboratory to trust for over 30 years.

Learn More
Trust

View the complete list of references

Leave the billing worries to us! NTD works hard to ensure that the billing process is simple and easy for your patients.

Interested in sending samples?

We can help you get started!

Contact Us for More Information